Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119239) titled 'Exploratory Clinical Study on the Dexamethasone-Free, Optimized Antiemetic Regimen with NEPA (Netupitant-Palonosetron) Capsules for Preventing Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately to Highly Emetogenic Chemotherapy(XDF-NEPA)' on Feb. 24.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Zhongshan Hospital Affiliated to Xiamen University
Condition:
chemotherapy-induced nausea and vomiting
Intervention:
A group:Administer an intravenous injection of 5 mg dexamethasone 0.5 hours before each chemotherapy cycle, and orally take one Netupitant-Palonoset...